Melody Harris - 11 May 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 May 2024, 21:38:09 UTC
Prior SEC filing
03 May 2024
Next SEC filing
03 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ali Olivo, Attorney-in-Fact

Key filing fact

Melody Harris filed Form 4 for NEOGENOMICS INC (NEO) on 14 May 2024.

Key facts

  • This page summarizes Melody Harris's Form 4 filing for NEOGENOMICS INC (NEO).
  • 3 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 14 May 2024, 21:38.

Change

  • Previous filing in this sequence was filed on 03 May 2024.
  • Current net transaction value: -$25,589.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+7,068
Change %
+6.9%
Price
$0.000000
Shares after
110,023
Date
11 May 2024
Ownership
Direct
Footnotes
F1
NEO transaction

Common Stock

Tax liability

Transaction value
$25,589
Shares
-1,722
Change %
-1.6%
Price
$14.86
Shares after
108,301
Date
11 May 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEO transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-7,068
Change %
-33%
Price
$0.000000
Shares after
14,136
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,068
Exercise price
$0.000000
Footnotes
F3, F4
NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
201,613
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
201,613
Exercise price
$9.24
Footnotes
F5
NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
39,683
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
39,683
Exercise price
$19.65
Footnotes
F6
NEO holding Derivative

Performance Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,204
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,204
Exercise price
$0.000000
Footnotes
F4, F7
NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
42,344
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
42,344
Exercise price
$16.45
Footnotes
F8
NEO holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,329
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,329
Exercise price
$0.000000
Footnotes
F4, F9
NEO holding Derivative

Performance Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,330
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,330
Exercise price
$0.000000
Footnotes
F4, F10
NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
19,984
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,984
Exercise price
$13.96
Footnotes
F11
NEO holding Derivative

Performance Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,939
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,939
Exercise price
$0.000000
Footnotes
F4, F12
NEO holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,939
Date
11 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,939
Exercise price
$0.000000
Footnotes
F4, F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

Footnote F2

Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

Footnote F3

On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

Footnote F4

Once vested, the shares of common stock are not subject to expiration.

Footnote F5

On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Footnote F6

On May 11, 2023, Ms. Harris was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.

Footnote F7

On May 11, 2023, Ms. Harris was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.

Footnote F8

On February 23, 2024, Ms. Harris was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.

Footnote F9

On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

Footnote F10

On February 23, 2024, Ms. Harris was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

Footnote F11

On May 2, 2024, Ms. Harris was granted 19,984 stock options. These options vest ratably over the first three anniversary dates of the grant date.

Footnote F12

On May 2, 2024, Ms. Harris was granted 11,939 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 17,909. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

Footnote F13

On May 2, 2024, Ms. Harris was granted 11,939 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .